Business · mergers-acquisitions

Cannabist Closes NJ Cultivation, Sells Three Retail Stores to Vireo

Bankrupt MSO shutters two New Jersey grow sites and offloads three dispensaries as asset liquidation accelerates.

By Priya Subramanian, Tax & Compliance ReporterPublished July 22, 20263 min read
Front view of a large modern warehouse with closed doors, showcasing industrial architecture

Front view of a large modern warehouse with closed doors, showcasing industrial architecture

The Cannabist Company will close two New Jersey cultivation facilities and sell three retail dispensaries to competitor Vireo Growth as part of its ongoing Chapter 11 bankruptcy liquidation, according to court filings made public July 22, 2026.

Cultivation Closures and Retail Divestiture

Cannabist will shutter two New Jersey grow operations while transferring three retail licenses to Vireo Growth under a bankruptcy-supervised asset sale. Public filings don't identify the cultivation sites by name. The retail locations are part of Cannabist's legacy New Jersey footprint acquired during the company's multi-state expansion from 2020 through 2023.

Vireo Growth, a vertically integrated operator active in New York, Maryland, and Minnesota, will acquire the three dispensaries as part of a broader portfolio realignment. The July 22 filing didn't disclose financial terms.

Bankruptcy Timeline and Asset Liquidation Strategy

Cannabist filed for Chapter 11 bankruptcy protection in May 2026, citing §280E tax burdens, operational losses, and $127 million in secured debt. Since then, the company has pursued a piecemeal liquidation strategy—selling state-specific assets to regional operators rather than attempting a whole-company sale.

New Jersey marks the third state where Cannabist has divested retail or cultivation operations since the bankruptcy filing. Prior sales? Colorado dispensaries went to a local operator in June. A Maryland cultivation license transferred to a private buyer in early July.

New Jersey Market Context

New Jersey's adult-use market launched in April 2022 and generated $1.9 billion in total cannabis sales in 2025. The state currently licenses 141 retail dispensaries and 73 cultivation facilities, according to the New Jersey Cannabis Regulatory Commission (CRC).

Before bankruptcy, Cannabist operated five retail locations and two cultivation sites in New Jersey. The sale to Vireo and the cultivation closures will reduce that footprint to two remaining dispensaries, both expected to be sold or closed by Q4 2026 under the liquidation plan.

Vireo Growth Expansion

Vireo Growth will expand its New Jersey presence from zero to three retail licenses through the acquisition. The company hasn't previously operated in New Jersey but has signaled interest in entering the state since adult-use sales began in 2022.

Vireo's acquisition is subject to CRC approval, which typically requires a 60-90 day review period for ownership transfers. Will the company rebrand the acquired dispensaries or operate them under Cannabist's existing trade names during a transition period? Vireo hasn't disclosed its plans.

Secured Creditor Position

Cannabist's $127 million secured debt is held by a syndicate led by Chicago Atlantic Real Estate Finance, which has approved the New Jersey asset sales as part of the liquidation waterfall. Secured creditors are expected to recover 60-75 cents on the dollar, according to bankruptcy counsel estimates filed in June.

Unsecured creditors—including cultivator suppliers and equipment lessors—are projected to recover less than 10% of claims under the current liquidation plan. A final distribution schedule should be filed in September 2026.

Remaining Asset Inventory

Cannabist retains operating licenses in six states as of July 22, 2026:

  • Virginia: 4 retail, 1 cultivation
  • Pennsylvania: 3 retail, 1 processing
  • Ohio: 2 retail
  • New Jersey: 2 retail (post-sale)
  • Illinois: 1 retail
  • Utah: 1 retail

All remaining assets are expected to be sold or closed by December 31, 2026, at which point the company will file for dissolution.

Tax and Compliance Implications

On a strict reading of IRC §280E, Cannabist can't deduct operating losses or asset write-downs from its federal tax liability, which complicates the bankruptcy estate's ability to offset liquidation gains. The company has reserved $18 million for federal tax obligations arising from asset sales, according to a June 15 disclosure statement.

New Jersey imposes a 6.625% sales tax on adult-use cannabis plus municipal taxes ranging from 0% to 2%. Cannabist's closure of cultivation operations will eliminate roughly $4.2 million in annual state tax obligations tied to those facilities, per the company's 2025 tax filings.

Sources

Cannabist CompanyVireo GrowthNew Jerseybankruptcy280Ecultivationretail
The CannIntel Daily

The cannabis newsletter you forward to your team.

Federal policy, market data, grower alerts, and the one story that matters today. Sent every weekday at 7am. Free.

No spam. Unsubscribe with one click. 21+ only.

Related from Business

More from the newsroom